Efficacy and Safety of Switching from Sitagliptin to Ipragliflozin in Obese Japanese Patients with Type 2 Diabetes Mellitus: A Single-Arm Multicenter Interventional Study.
Kentaro WatanabeSusumu YamaguchiYoshinori KosakaiTetsuya IojiHisamitsu IshiharaPublished in: Clinical drug investigation (2023)
Japan Registry of Clinical Trials identifier: jRCT#031190022.